54322-65-5,MFCD11110393
Catalog No.:AA00DCCO

54322-65-5 | Cyclopropylacetyl chloride

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
95%
in stock  
$97.00   $68.00
- +
250mg
95%
in stock  
$122.00   $85.00
- +
1g
95%
in stock  
$202.00   $142.00
- +
5g
95%
in stock  
$702.00   $492.00
- +
25g
95%
in stock  
$2,680.00 $1,876.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00DCCO
Chemical Name:
Cyclopropylacetyl chloride
CAS Number:
54322-65-5
Molecular Formula:
C5H7ClO
Molecular Weight:
118.5615
MDL Number:
MFCD11110393
SMILES:
ClC(=O)CC1CC1
Properties
Computed Properties
 
Complexity:
86.1  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.8  

Downstream Synthesis Route

[1]Bouzoubaa,Mohamed;Leclerc,Gerard;Decker,Nicole;Schwartz,Jean;Andermann,Guy[JournalofMedicinalChemistry,1984,vol.27,#10,p.1291-1294]

[1]Patent:WO2005/49033,2005,A1.Locationinpatent:Page/Pagecolumn101

[2]Patent:WO2015/32790,2015,A1.Locationinpatent:Page/Pagecolumn32

[3]Patent:WO2015/110435,2015,A1.Locationinpatent:Page/Pagecolumn55

[4]OrganicandBiomolecularChemistry,2013,vol.11,p.5994-5997

[5]Molecules,2014,vol.19,p.1527-1543

[6]Patent:US2006/25477,2006,A1.Locationinpatent:Page/Pagecolumn8

[7]JournalofMedicinalChemistry,1984,vol.27,p.1291-1294

[8]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

[9]Patent:US2006/94750,2006,A1.Locationinpatent:Page/Pagecolumn30

[10]Patent:WO2006/134341,2006,A1.Locationinpatent:Page/Pagecolumn68-69

[11]Patent:WO2007/9236,2007,A1.Locationinpatent:Page/Pagecolumn60

[12]Patent:US2008/188533,2008,A1.Locationinpatent:Page/Pagecolumn42

[13]Patent:US2008/214601,2008,A1.Locationinpatent:Page/Pagecolumn9

[14]JournaloftheAmericanChemicalSociety,2008,vol.130,p.13231-13233

[15]Patent:US2010/144745,2010,A1.Locationinpatent:Page/Pagecolumn48

[16]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.5074-5079

[17]Patent:US2011/130445,2011,A1.Locationinpatent:Page/Pagecolumn66

[18]JournaloftheAmericanChemicalSociety,2013,vol.135,p.7339-7348

[19]Patent:US2013/245042,2013,A1.Locationinpatent:Paragraph0102

[20]Patent:WO2013/192306,2013,A1.Locationinpatent:Page/Pagecolumn21

[21]MedChemComm,2014,vol.5,p.57-63

[22]Patent:WO2014/110705,2014,A1.Locationinpatent:Page/Pagecolumn131

[23]Patent:WO2014/151863,2014,A1.Locationinpatent:Page/Pagecolumn48

[24]Synthesis,2015,vol.47,p.1091-1100

[25]OrganicLetters,2015,vol.17,p.5898-5901

[26]ChemicalandPharmaceuticalBulletin,2016,vol.64,p.602-608

[27]Patent:WO2017/31325,2017,A1.Locationinpatent:Paragraph0668;0679

[28]Patent:WO2017/102091,2017,A1.Locationinpatent:Page/Pagecolumn346

[29]JournaloftheAmericanChemicalSociety,2017,vol.139,p.12153-12156

[30]EuropeanJournalofMedicinalChemistry,2018,vol.157,p.962-977

[31]OrganicLetters,2020,vol.22,p.234-238

[32]Patent:WO2019/213386,2019,A1.Locationinpatent:Paragraph0175

[33]Patent:WO2020/88659,2020,A1.Locationinpatent:Paragraph00232

[1]Fenick,DavidJ.;Falvey,DanielE.[JournalofOrganicChemistry,1994,vol.59,#17,p.4791-4799]

[2]Leber,PhyllisA.;Nocket,AnthonyJ.;Wipperman,MatthewF.;Zohrabian,Sylvia;Bemis,ChristopherY.;Sidhu,MunshaK.[OrganicandBiomolecularChemistry,2013,vol.11,#36,p.5994-5997]

[3]Leber,PhyllisA.;Nocket,AnthonyJ.;Hancock-Cerutti,William;Bemis,ChristopherY.;Khine,WintKhant;MohrbacherIII,JosephA.;Baldwin,JohnE.[Molecules,2014,vol.19,#2,p.1527-1543]

[4]CurrentPatentAssignee:DENALITHERAPEUTICSINC-WO2017/31325,2017,A1

[1]Patent:US6407114,2002,B1.Locationinpatent:Pagecolumn20

723282-37-9    54322-65-5   
C28H27N3O2 

[1]Patent:WO2004/58759,2004,A1.Locationinpatent:Page166

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:54322-65-5 Molecular Formula|54322-65-5 MDL|54322-65-5 SMILES|54322-65-5 Cyclopropylacetyl chloride
Catalog No.: AA00DCCO
54322-65-5,MFCD11110393
54322-65-5 | Cyclopropylacetyl chloride
Pack Size: 100mg
Purity: 95%
in stock
$97.00 $68.00
Pack Size: 250mg
Purity: 95%
in stock
$122.00 $85.00
Pack Size: 1g
Purity: 95%
in stock
$202.00 $142.00
Pack Size: 5g
Purity: 95%
in stock
$702.00 $492.00
Pack Size: 25g
Purity: 95%
in stock
$2,680.00 $1,876.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00DCCO
Chemical Name: Cyclopropylacetyl chloride
CAS Number: 54322-65-5
Molecular Formula: C5H7ClO
Molecular Weight: 118.5615
MDL Number: MFCD11110393
SMILES: ClC(=O)CC1CC1
Properties
Complexity: 86.1  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 7  
Hydrogen Bond Acceptor Count: 1  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.8  
Downstream Synthesis Route
54322-65-5    506-82-1    4160-75-2 

[1]Bouzoubaa,Mohamed;Leclerc,Gerard;Decker,Nicole;Schwartz,Jean;Andermann,Guy[JournalofMedicinalChemistry,1984,vol.27,#10,p.1291-1294]

5239-82-7    54322-65-5 

[1]Patent:WO2005/49033,2005,A1.Locationinpatent:Page/Pagecolumn101

[2]Patent:WO2015/32790,2015,A1.Locationinpatent:Page/Pagecolumn32

[3]Patent:WO2015/110435,2015,A1.Locationinpatent:Page/Pagecolumn55

[4]OrganicandBiomolecularChemistry,2013,vol.11,p.5994-5997

[5]Molecules,2014,vol.19,p.1527-1543

[6]Patent:US2006/25477,2006,A1.Locationinpatent:Page/Pagecolumn8

[7]JournalofMedicinalChemistry,1984,vol.27,p.1291-1294

[8]JournalofOrganicChemistry,1994,vol.59,p.4791-4799

[9]Patent:US2006/94750,2006,A1.Locationinpatent:Page/Pagecolumn30

[10]Patent:WO2006/134341,2006,A1.Locationinpatent:Page/Pagecolumn68-69

[11]Patent:WO2007/9236,2007,A1.Locationinpatent:Page/Pagecolumn60

[12]Patent:US2008/188533,2008,A1.Locationinpatent:Page/Pagecolumn42

[13]Patent:US2008/214601,2008,A1.Locationinpatent:Page/Pagecolumn9

[14]JournaloftheAmericanChemicalSociety,2008,vol.130,p.13231-13233

[15]Patent:US2010/144745,2010,A1.Locationinpatent:Page/Pagecolumn48

[16]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.5074-5079

[17]Patent:US2011/130445,2011,A1.Locationinpatent:Page/Pagecolumn66

[18]JournaloftheAmericanChemicalSociety,2013,vol.135,p.7339-7348

[19]Patent:US2013/245042,2013,A1.Locationinpatent:Paragraph0102

[20]Patent:WO2013/192306,2013,A1.Locationinpatent:Page/Pagecolumn21

[21]MedChemComm,2014,vol.5,p.57-63

[22]Patent:WO2014/110705,2014,A1.Locationinpatent:Page/Pagecolumn131

[23]Patent:WO2014/151863,2014,A1.Locationinpatent:Page/Pagecolumn48

[24]Synthesis,2015,vol.47,p.1091-1100

[25]OrganicLetters,2015,vol.17,p.5898-5901

[26]ChemicalandPharmaceuticalBulletin,2016,vol.64,p.602-608

[27]Patent:WO2017/31325,2017,A1.Locationinpatent:Paragraph0668;0679

[28]Patent:WO2017/102091,2017,A1.Locationinpatent:Page/Pagecolumn346

[29]JournaloftheAmericanChemicalSociety,2017,vol.139,p.12153-12156

[30]EuropeanJournalofMedicinalChemistry,2018,vol.157,p.962-977

[31]OrganicLetters,2020,vol.22,p.234-238

[32]Patent:WO2019/213386,2019,A1.Locationinpatent:Paragraph0175

[33]Patent:WO2020/88659,2020,A1.Locationinpatent:Paragraph00232

6542-60-5    54322-65-5 

[1]Fenick,DavidJ.;Falvey,DanielE.[JournalofOrganicChemistry,1994,vol.59,#17,p.4791-4799]

[2]Leber,PhyllisA.;Nocket,AnthonyJ.;Wipperman,MatthewF.;Zohrabian,Sylvia;Bemis,ChristopherY.;Sidhu,MunshaK.[OrganicandBiomolecularChemistry,2013,vol.11,#36,p.5994-5997]

[3]Leber,PhyllisA.;Nocket,AnthonyJ.;Hancock-Cerutti,William;Bemis,ChristopherY.;Khine,WintKhant;MohrbacherIII,JosephA.;Baldwin,JohnE.[Molecules,2014,vol.19,#2,p.1527-1543]

[4]CurrentPatentAssignee:DENALITHERAPEUTICSINC-WO2017/31325,2017,A1

54322-65-5    109-77-3    264919-84-8 

[1]Patent:US6407114,2002,B1.Locationinpatent:Pagecolumn20

723282-37-9    54322-65-5   
C28H27N3O2 

[1]Patent:WO2004/58759,2004,A1.Locationinpatent:Page166

Building Blocks More >
5094-12-2
5094-12-2
2-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
AA00DCJ0 | MFCD00460783
53441-14-8
53441-14-8
N-Methyl bromofluoroacetamide
AA00DCN6 | MFCD04038318
55161-63-2
55161-63-2
MERCAPTOMETHYLMETHYLDIETHOXYSILANE
AA00DCRO | MFCD00054927
4313-56-8
4313-56-8
(1-Aminocyclohexyl)methanol
AA00DCVL | MFCD12198034
52708-36-8
52708-36-8
4-(1H-Benzimidazol-1-yl)aniline
AA00DCZ3 | MFCD04971066
439121-19-4
439121-19-4
3-Amino-3-(5-methyl-2-furyl)propanoic acid
AA00DD3H | MFCD02661897
55637-63-3
55637-63-3
2-ACETAMIDO-2-DEOXY-4-O-(BETA-D-MANNOPYRANOSYL)-D-GLUCOSE
AA00DD7O | MFCD01310846
540-04-5
540-04-5
7,7,8,8,11,11,12,12-octahydro-psi,psi-carotene
AA00DDE1 | MFCD22666385
41828-04-0
41828-04-0
3-METHOXY-2-PROPOXYBENZALDEHYDE OXIME
AA00DDJT | MFCD09710937
5442-91-1
5442-91-1
4-(Ethoxycarbonyl)-3,5-dimethyl-1h-pyrrole-2-carboxylic acid
AA00DDS9 | MFCD00030408
Submit
© 2017 AA BLOCKS, INC. All rights reserved.